Ibm Retirement Fund Gilead Sciences, Inc. Transaction History

Ibm Retirement Fund

$72.1 Million
Q2 2022

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$57.72 - $65.01 $1.15 Million - $1.3 Million	-19,994 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $52,707 - $66,047	-910 Reduced 4.35%	19,994 $1.19 Million
Q4 2021 Jan 19, 2022	SELL	$64.88 - $73.64 $942,381 - $1.07 Million	-14,525 Reduced 41.0%	20,904 $1.52 Million
Q3 2021 Oct 05, 2021	BUY	$67.69 - $73.03 $5,889 - $6,353	87 Added 0.25%	35,429 $2.48 Million
Q2 2021 Jul 12, 2021	SELL	$63.47 - $69.35 $471,962 - $515,686	-7,436 Reduced 17.38%	35,342 $2.43 Million
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $232,800 - $265,624	-3,880 Reduced 8.32%	42,778 $2.77 Million
Q4 2020 Jan 25, 2021	BUY	$56.65 - $64.55 $208,188 - $237,221	3,675 Added 8.55%	46,658 $2.72 Million
Q3 2020 Oct 16, 2020	BUY	$62.1 - $78.08 $712,597 - $895,968	11,475 Added 36.42%	42,983 $2.72 Million
Q2 2020 Jul 08, 2020	SELL	$72.34 - $84.0 $56,497 - $65,604	-781 Reduced 2.42%	31,508 $2.42 Million
Q1 2020 Apr 07, 2020	BUY	$62.63 - $80.22 $711,476 - $911,299	11,360 Added 54.28%	32,289 $2.41 Million
Q4 2019 Jan 07, 2020	SELL	$61.62 - $67.78 $48,803 - $53,681	-792 Reduced 3.65%	20,929 $1.36 Million
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $14,502 - $16,008	-232 Reduced 1.06%	21,721 $1.38 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $15,343 - $17,206	248 Added 1.14%	21,953 $1.48 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $4,314 - $4,833	-69 Reduced 0.32%	21,705 $1.41 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $93,715 - $122,292	-1,548 Reduced 6.64%	21,774 $1.36 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $260,100 - $287,979	-3,649 Reduced 13.53%	23,322 $1.8 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $250,566 - $292,276	-3,862 Reduced 12.53%	26,971 $1.91 Million
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $90,321 - $110,112	-1,240 Reduced 3.87%	30,833 $2.32 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $17,787 - $20,880	-250 Reduced 0.77%	32,073 $2.52 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $2.33 Million - $2.76 Million	32,323	32,323 $2.88 Million

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.12 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.75 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.6 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.

Account